These findings revise and expand the known role of MHC class I in CD8<sup>+</sup> T cell and natural killer cell immunity and demonstrate a previously unrecognized role in CD4<sup>+</sup> T cell-mediated cancer and alloimmunity. Here, CD8A is linked to cancer.